Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National, Prospective, Observational, Cohort Study of Venous Thromboembolism (VTE) Management With the Low Molecular Weight Heparin, Enoxaparin, in the Outpatient Setting in Canada

NCT01133002 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01133002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01133002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National, Prospective, Observational, Cohort Study of Venous Thromboembolism (VTE) Management With the Low Molecular Weight Heparin, Enoxaparin, in the Outpatient Setting in Canada
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2010
Enrollment
915 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medical prevention therapy